Loss of Astrocytic µ Opioid Receptors Exacerbates Aversion Associated with Morphine Withdrawal in Mice: Role of Mitochondrial Respiration
Authors:
- Kateryna MurlanovaKateryna Murlanova
- Yan JouroukhinYan Jouroukhin
- Ksenia Novototskaya-VlasovaKsenia Novototskaya-Vlasova
- Shovgi HuseynovShovgi Huseynov
- Olga PletnikovaOlga Pletnikova
- Michael J. MoralesMichael J. Morales
- Yun GuanYun Guan
- Atsushi KamiyaAtsushi Kamiya
- Dwight E. BerglesDwight E. Bergles
- David M. DietzDavid M. Dietz
- Mikhail V. PletnikovMikhail V. Pletnikov
Open Access
Abstract
Astrocytes express mu/µ opioid receptors, but the function of these receptors remains poorly understood. We evaluated the effects of astrocyte-restricted knockout of µ opioid receptors on reward- and aversion-associated behaviors in mice chronically exposed to morphine. Specifically, one of the floxed alleles of the Oprm1 gene encoding µ opioid receptor 1 was selectively deleted from brain astrocytes in Oprm1 inducible conditional knockout (icKO) mice. These mice did not exhibit changes in locomotor activity, anxiety, or novel object recognition, or in their responses to the acute analgesic effects of morphine. Oprm1 icKO mice displayed increased locomotor activity in response to acute morphine administration but unaltered locomotor sensitization. Oprm1 icKO mice showed normal morphine-induced conditioned place preference but exhibited stronger conditioned place aversion associated with naloxone-precipitated morphine withdrawal. Notably, elevated conditioned place aversion lasted up to 6 weeks in Oprm1 icKO mice. Astrocytes isolated from the brains of Oprm1 icKO mice had unchanged levels of glycolysis but had elevated oxidative phosphorylation. The basal augmentation of oxidative phosphorylation in Oprm1 icKO mice was further exacerbated by naloxone-precipitated withdrawal from morphine and, similar to that for conditioned place aversion, was still present 6 weeks later. Our findings suggest that µ opioid receptors in astrocytes are linked to oxidative phosphorylation and they contribute to long-term changes associated with opioid withdrawal.Keywords
Funding Information
- Johns Hopkins University Drug Abuse Center (R01NS110598, R01NS117761, R01DA041208, MH083728, MH094268)
- National Institute of Neurological Disorders and Stroke (R01NS110598, R01NS117761, R01DA041208, MH083728, MH094268)
- National Institute of Drug Abuse (R01NS110598, R01NS117761, R01DA041208, MH083728, MH094268)
- National Institute of Mental Health (R01NS110598, R01NS117761, R01DA041208, MH083728, MH094268)
This publication has 62 references indexed in Scilit:
- Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout MicePLOS ONE, 2013
- The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolismNeurochemistry International, 2012
- Accumbal dopamine, noradrenaline and serotonin activity after naloxone-conditioned place aversion in morphine-dependent miceNeurochemistry International, 2012
- Co-compartmentalization of the Astroglial Glutamate Transporter, GLT-1, with Glycolytic Enzymes and MitochondriaJournal of Neuroscience, 2011
- Reward Processing by the Opioid System in the BrainPhysiological Reviews, 2009
- Functional characterization of human variants of the mu-opioid receptor geneProceedings of the National Academy of Sciences, 2009
- Glutamate Transporter Coupling to Na,K-ATPaseThe Journal of Neuroscience, 2009
- Inhibition of mitochondrial function in astrocytes: implications for neuroprotectionJournal of Neurochemistry, 2007
- The psychology and neurobiology of addiction: an incentive–sensitization viewAddiction, 2000
- Are astroglial cells involved in morphine tolerance?Neurochemical Research, 1988